Design care for every beginning
Awareness matters. Reliable systems matter more. Healthcare executives can connect prevention, respectful screening, diagnostic closure, birth readiness, newborn follow-up, and lifelong support into one accountable care pathway.
The leadership signal
January is Birth Defects Awareness Month. In 2026, the Centers for Disease Control and Prevention states that birth defects are structural changes present at birth that can affect almost any part of the body. They range from mild to serious, and many babies need specialized care and intervention to thrive.
The national burden is substantial. CDC reports that birth defects affect about 1 in every 33 babies born in the United States. They are also the leading cause of infant death, accounting for about 20 percent, or 1 in 5, of infant deaths. For hospital leaders, these figures point to a system responsibility that reaches from primary care and obstetrics to maternal-fetal medicine, neonatal services, pediatric specialties, rehabilitation, and community support.
Awareness should expose the gaps between services
Many organizations already provide high-quality clinical care inside individual departments. Reliability problems appear at the handoffs. A patient may receive a prenatal screening result without timely diagnostic counseling. A fetal diagnosis may be documented without a coordinated delivery plan. A newborn may complete screening while the responsible team for an out-of-range result remains unclear. A family may leave the hospital with several specialty appointments but no single point of coordination.
These are not isolated communication problems. They are operating-model problems. Executives should assess whether the organization can move a family from one stage to the next without depending on individual persistence, insider knowledge, or the ability to navigate multiple disconnected systems.
Access
Can patients obtain preconception care, prenatal services, appropriate screening, diagnostic testing, and specialty consultation without avoidable delay?
Ownership
Does every screening or diagnostic result have a named owner, a defined escalation rule, and documented family communication?
Continuity
Do maternal, newborn, pediatric, surgical, rehabilitation, and community teams share an actionable plan across settings?
A four-stage reliability continuum
The executive aim is not to maximize testing. It is to provide the right information, at the right time, with informed consent, appropriate interpretation, and dependable follow-through. Screening estimates the likelihood of certain conditions. It does not provide a definitive diagnosis. Diagnostic testing, specialist counseling, and family preferences must remain clearly distinguished.
Prepare
Strengthen preconception and prenatal access. Support medication review, chronic-condition management, vaccination, infection prevention, and folic-acid education.
Detect
Offer evidence-based screening and diagnostic pathways with clear consent, accurate interpretation, genetics access, and result ownership.
Ready
Convert a prenatal diagnosis into a delivery, neonatal stabilization, surgery, transfer, palliative care, or specialty plan before birth whenever possible.
Connect
Close the loop on newborn screening, primary care, early intervention, specialty follow-up, family support, and transitions across the life course.
Prevention without overpromising
CDC notes that a complex mix of genetic, behavioral, and environmental factors may contribute to many birth defects, and that the causes of most conditions remain unknown. Executives should therefore reject campaigns that imply every condition is preventable. A stronger approach gives patients practical, evidence-based opportunities to reduce risk while acknowledging scientific uncertainty.
One clear example is folic acid. CDC recommends 400 micrograms of folic acid daily before and during early pregnancy to help prevent neural tube defects. Health systems can make that guidance more reliable through primary-care prompts, preconception counseling, pharmacy partnerships, discharge education, and culturally appropriate patient materials. Organizations should also support safe medication review, diabetes management, infection prevention, vaccination, and avoidance of alcohol, tobacco, and non-prescribed drugs during pregnancy. Patients should not stop prescribed medications without consulting their clinician.
The operational lesson is simple. Education alone does not guarantee access or action. Leaders should examine whether the system makes the safer choice easier, affordable, understandable, and available before pregnancy begins.
Six executive decisions that improve reliability
Name an accountable pathway owner
Assign executive and clinical leaders for the maternal-infant congenital conditions pathway. Ownership should include data, handoffs, equity, and family experience, not only individual department performance.
Define screening-to-diagnosis closure
Measure the time from an abnormal or higher-risk screen to patient notification, counseling, recommended diagnostic evaluation, and a documented plan. Track unresolved results as safety events.
Build prenatal birth-readiness huddles
For anticipated complex births, bring obstetrics, maternal-fetal medicine, neonatology, anesthesia, surgery, nursing, transport, social work, and palliative care together before delivery.
Standardize newborn-screening follow-up
HRSA describes newborn screening as a state-based public health program. Each organization still needs explicit owners for specimen quality, result receipt, family contact, confirmatory testing, referral, and escalation.
Measure equity at every handoff
Stratify access, time to diagnosis, missed appointments, transfer patterns, and follow-up by race, ethnicity, language, geography, payer, and other locally relevant factors. Do not mistake an average for equitable performance.
Design for lifelong support
Birth defects are not only neonatal events. Connect families to a medical home, condition-specific specialists, early intervention, rehabilitation, behavioral health, schools, social services, and adult-care transition planning.
Newborn screening requires fast, closed-loop operations
HRSA states that newborn screening in the United States includes blood spot screening, pulse oximetry screening, and hearing screening. Programs are state-based, and the conditions included on screening panels can vary. Most states screen for some or all conditions on the Recommended Uniform Screening Panel, while some add other conditions.
For executives, the main risk is not whether a screening test was ordered. It is whether every step after an out-of-range result happened quickly and was documented. A reliable process confirms that the sample was adequate, the result reached the right team, the family received understandable communication, confirmatory testing was completed, and the appropriate specialist accepted the referral. Dashboards should distinguish tests completed from episodes fully closed.
The executive scorecard
| Domain | Measure | Executive question |
|---|---|---|
| Preconception access | Timely visits, folic-acid counseling, medication review, chronic-condition optimization | Which populations encounter the greatest barriers before pregnancy? |
| Prenatal closure | Days from higher-risk screen to counseling, diagnostic decision, and completed plan | Who owns unresolved or delayed results? |
| Birth readiness | Percent of anticipated complex births with a multidisciplinary plan before delivery | Is the receiving team prepared for the first hour of life? |
| Newborn screening | Specimen quality, completion, result receipt, follow-up time, confirmatory testing | Do we measure completed tests or completed episodes? |
| Continuity | Primary care, specialty, early-intervention, and family-support connection | Can a family identify one coordinating team? |
| Equity | All measures stratified by locally relevant demographic and access variables | Where do outcomes diverge, and what system factor can we change? |
A practical 90-day leadership plan
Map and baseline
- Map the full care pathway across departments and community partners.
- Identify screening, referral, transfer, and follow-up failure points.
- Establish baseline measures and stratify them for equity.
- Include parents and people living with congenital conditions in the review.
Standardize ownership
- Assign named owners for every result and referral class.
- Create escalation rules for delays and missed handoffs.
- Standardize birth-readiness huddles and family communication.
- Verify newborn-screening responsibilities with state requirements.
Test and govern
- Pilot the pathway in one service line or facility.
- Review defects, delays, near misses, and family feedback weekly.
- Report closure measures to the quality committee.
- Fund the next constraints that limit timely access or follow-up.
Conclusion: design care for every beginning
Birth Defects Awareness Month should do more than generate messages in January. It should prompt leaders to examine whether families experience one coordinated system or a series of disconnected services. The strongest organizations will pair accurate prevention guidance with respectful screening, diagnostic clarity, prepared clinical teams, closed-loop newborn follow-up, and lifelong support.
Executives cannot eliminate every risk or prevent every condition. They can remove avoidable delays, clarify ownership, reduce inequitable access, and make complex care easier to navigate. That is the practical leadership promise behind designing care for every beginning.
Authoritative resources
- CDC: Birth Defects Awareness Month
- CDC: About Birth Defects
- CDC: Data and Statistics on Birth Defects
- CDC: Neural Tube Defects and Folic Acid
- HRSA: Newborn Screening Information Center
- HRSA: Recommended Uniform Screening Panel
- NICHD: Congenital Anomalies
This executive brief supports organizational planning and education. It does not replace individualized medical advice, diagnostic counseling, or state-specific newborn-screening requirements.
